CAR Magazine on MSN
Untitled [www.msn.com]
From the CAR+ archive: the 2011 BMW M5 (F10) vs the greatest M cars – including M1, M3, CSL, GTS and 1M ...
Tim Pitt drives the new 2025 BMW M3 CS Touring, a practical family estate car with a beguiling 550hp wild side.
BMW has opted to switch to traditional transmissions due to their improved comfort over DCTs, which can have jerky shifts.
Motoring Research on MSN
BMW M3 CS Touring 2025 review
Tim Pitt drives the new 2025 BMW M3 CS Touring, a practical family estate car with a beguiling 550hp wild side.
YouTube on MSN
E46 M3 CSL Dyno Test Power Run
We put our E46 M3 CSL on the dyno to find out exactly how much power it’s making after years on the road. Known for its ...
Forget one of one: this particular BMW 3.0 CSL is, quite literally, the very first M race car, and it's up for sale for presumably many dollars.
Top Gear on MSN
Want to drive Hamilton's Ferrari F1 car around the 'Ring? Now you can… in Assetto Corsa Evo
Also to be added is the 2025 Ferrari SF25 F1 car which Charles Leclerc and Lewis Hamilton have driven to various baffling low ...
CSL's share price has declined by 35% in 2025, influenced by a challenging US healthcare industry and cautious growth prospects. Despite headwinds, UBS sees potential medium-term recovery, especially ...
Amid uncertainty for its vaccine division, CSL is growing the footprint of its bread-and-butter plasma therapies business by pledging a capital investment of about $1.5 billion for U.S.-based ...
SYDNEY--Australia-based pharmaceutical company CSL plans to expand its U.S. production over the next five years as part of a $1.5 billion investment in the country. CSL, which produces plasma-derived ...
CSL will invest $2.3 billion to expand its North American manufacturing facilities over the next five years, joining other global pharmaceutical companies seeking exemptions from US President Donald ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results